| 15-Oct-2025 |
Jeevan Scienti.
|
Inter alia, to consider and approve:- 1. To consider and evaluate a proposal for raising funds through the issuance of one or more instruments, including equity shares, warrants convertible into equity shares, or other securities, by way of preferential issue, private placement or any other permissible mode(s), in accordance with the applicable provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws, subject to necessary approvals including approval of the shareholders and other statutory/regulatory authorities, as may be required. 2. To consider convening a General Meeting of the members of the Company to seek their approval for the aforementioned fund-raising proposal. 3. Any other business with the permission of the Chair. |
| 15-Oct-2025 |
Virinchi
|
Virinchi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 inter alia to consider and approve the following agenda item:
1. Proposal for raising of funds in one or more tranches by issue of equity shares and/or any other instruments or eligible securities representing either equity shares and/or convertible securities linked to equity shares or through any other permissible mode or a combination thereof preferential allotment private placement or any other method in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended from time to time and other applicable law to such investors as may be permitted to invest in such issuance of securities as deemed appropriate subject to approval of the shareholders of the Company and receipt of other regulatory/statutory approvals.
2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal for raising of funds as required.
Virinchi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 ,inter alia, to consider and approve the following agenda item: 1. Proposal for raising of funds, in one or more tranches, by issue of equity shares and/or any other instruments or eligible securities representing either equity shares and/or convertible securities linked to equity shares or through any other permissible mode or a combination thereof, preferential allotment, private placement, or any other method in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, from time to time, and other applicable law, to such investors, as may be permitted to invest in such issuance of securities, as deemed appropriate, subject to approval of the shareholders of the Company and receipt of other regulatory/statutory approvals. 2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal for raising of funds, as required.
(As Per BSE Announcement Dated On : 11.10.2025) |
| 15-Oct-2025 |
HDFC AMC
|
HDFC Asset Management Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half year ending September30 2025. |
| 15-Oct-2025 |
Welspun Enterp
|
Welspun Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 inter alia to consider and approve the proposal of fund raising through issuance of convertible equity warrants and ancillary actions in this regard through preferential issue under the applicable laws rules and regulations and subject to the requisite regulatory/ statutory approvals and the approval of the shareholders of the Company. |
| 15-Oct-2025 |
HDFC Life Insur.
|
HDFC Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30 2025 and raising of funds in one or more tranches by way of issuance of Non-Convertible Debentures in the nature of subordinated debt instrument. |